In a significant development for women’s healthcare, KEM Hospital, Mumbai, has launched its largest and most expensive BMC-funded clinical trial. The study will involve 7,000 women and aims to revolutionize breast cancer diagnosis through artificial intelligence. Running over 12 to 28 months, the trial evaluates a small, portable AI-enabled thermal imaging device.
A Comfortable, Contact-Free Alternative to Mammography
Unlike traditional mammograms, the device under trial offers a non-invasive, pain-free experience. It eliminates physical contact and breast compression, making the screening more comfortable. During the test, patients sit alone in a private, curtained room at a set distance from the thermal imaging device, ensuring privacy and ease.
Advanced AI Technology from NIRAMAI in Use
Developed by Bengaluru-based startup NIRAMAI Health Analytix, the device houses a high-resolution thermal sensor and advanced AI algorithms. It maps over 400,000 temperature points on the chest to detect abnormalities. Within 24 hours, the system generates a “breast health score” indicating whether a condition is benign, malignant, or needs further evaluation.
Clinical Trial Supported by BMC’s Startup Incubation Programme
As reported by TOI, the device, valued at ₹50 lakh, is currently installed at KEM Hospital at no cost as part of a clinical validation effort under the BMC’s startup incubation programme. Notably, this trial marks the largest BMC-funded health study to date.
“We are moving forward with this only on the condition that the machine stays at KEM if the trial results are favourable,” confirmed Dr. Shilpa Rao, Associate Professor of General Surgery and Principal Investigator of the study.
Addressing Challenges of Thermal Imaging with AI
Dr. Rao acknowledged that while thermal imaging has existed since the 2000s, its broad heat detection capabilities can sometimes result in false positives—identifying infections or inflammations as potential tumors.
“This leads to avoidable psychological stress and financial strain for patients,” she explained. However, the integration of AI helps refine accuracy and minimize unnecessary interventions.
All Participants to Undergo Comparative Testing
As part of the trial, each participant will undergo three diagnostic tests: mammography, ultrasound, and the AI-based thermal scan. Doctors will compare the results to evaluate the effectiveness and accuracy of the new technology.
Dedicated Breast Care Ward Finally a Reality
In a parallel achievement, KEM Hospital has opened a dedicated 15-bed ward exclusively for breast-related conditions. This milestone comes 14 years after the hospital launched Mumbai’s first breast clinic at a civic-run institution.
“I have been advocating for this ward since 2010,” said Dr. Rao. “Perhaps having a woman as the dean made the difference this time.”
Leadership Committed to Women’s Health
Dr. Sangeeta Ravat, Dean of KEM Hospital, expressed personal commitment to the initiative.
“The issue is very close to my heart. Breast cancer patients are often immunocompromised and need special care. We faced hurdles before, but they’ve now been resolved,” she said.
Dr. Varsha Kulkarni, Head of the General Surgery Department, also played a crucial role in establishing the ward.
“Women’s health deserves priority,” she emphasized.
Conclusion
With its dual focus on cutting-edge technology and dedicated patient care, KEM Hospital is setting new standards in breast cancer detection and treatment. This initiative not only promises to reshape screening practices but also reinforces the importance of gender-sensitive healthcare infrastructure.